Events

Research infrastructures info day 2023 calls
DEC
Tue
06
09:00 - 15:30

This was 3 years ago

Location

virtual

Programmes
Research Infrastructures

Horizon Europe’s Research Infrastructures actions support the development of an integrated, inter-operable and effective ecosystem of Research Infrastructures and Technology Infrastructures in Europe. The info day will focus on the 2023 calls of the Work programme 2023-2024, for its different destinations:

  • INFRADEV – Developing, consolidating and optimising the European research infrastructures landscape, maintaining global leadership
  • INFRASERV – RI services to support health research, accelerate the green and digital transformation, and advance frontier knowledge
  • INFRATECH – Next generation of scientific instrumentation, tools, methods, and advanced digital solutions for RIs
    targeting the development of the next generation of scientific instrumentation, tools, methods, and advanced digital solutions for Research Infrastructures
  • INFRAEOSC – Enabling an operational, open and FAIR European Open Science Cloud ecosystem

In addition, the Info day will offer horizontal information on the submission, evaluation and management of the 2023 Research Infrastructures calls.

Recordings and presentations

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.